Page 335 - IJB-10-6
P. 335

International Journal of Bioprinting                            3D-printed PPDO/GO stents for CHD treatment




               Vascular stents are one of the medical devices   With the incorporation of GO, the quantity of adhered
            that are directly in contact with blood; hence, the   platelets decreases. According to  Figure 6c, the number
            hemocompatibility of PPDO/GO stents needs to be    of adhered platelets per unit area for PPDO/0.2%GO
            evaluated to avoid hemolysis and thrombosis. During   and PPDO/0.5%GO are 6853.25 ± 1237.32 and 4405.66
                                                                           −2
            hemolysis, RBCs rupture; free hemoglobin, intracellular   ± 1207.06 mm , respectively, and are significantly lower
                                                                                                           −2
            components, and pro-thrombotic substances are released   than that of pristine PPDO (12346.72 ± 1225.30 mm ).
            into the plasma, activating the coagulation cascade and   Additionally, there is a significant statistical difference
            leading to thrombosis.  According to the ISO 10993-4   between the PPDO/0.2% and PPDO/0.5% groups. The
                               92
            standard, a hemolysis rate lower than 5% is acceptable for   SEM images (Figure 6d–f) also demonstrate the trend of
            blood-contacting  biomaterials.  Results  of  the  hemolysis   a smaller quantity of adhered platelets with the increase of
            test (Figure 6a and b) revealed that the hemolysis rates of   GO content. The adhered platelets in all groups demonstrate
            all samples are below 1%, indicating that PPDO/GO stents   a round shape without protruded pseudopodia, suggesting
            are acceptable and do not cause hemolysis.         a non-activated state. GO introduces a large number of
                                                               hydrophilic  groups,  which  conduce  albumin  adsorption
               After adherence to the stent surface, platelets can be   and competitively inhibit fibrinogen adsorption. This
            activated and aggregate, causing thrombosis, inflammation,   forms a protective layer on the surface of the material to
            and even restenosis. 93,94  Therefore, it is essential to evaluate   prevent the direct contact of platelets, thus reducing the
            the level of platelet adhesion of PPDO/GO stents.   adhesion and activation of platelets. 95












































            Figure 5. Photos of 3D-printed PPDO/GO and PPDO sliding-lock stents and corresponding compression performance. (a) 3D-printed PPDO/GO and
            PPDO sliding-lock stents in the initial expanding state. (b and c) Front view (b) and top view (c) of PPDO/GO and PPDO sliding-lock stents in the locked
            state. From left to right: PPDO, PPDO/0.2%GO, and PPDO/0.5%GO stents, respectively. (d) Compression force of PPDO/GO and PPDO sliding-lock
            stents measured by parallel plate compression test. ***p < 0.001. (e–g) SEM images of the surface morphology of 3D-printed PPDO/GO and PPDO sliding-
            lock stents: (e) PPDO; (f) PPDO/0.2%GO; and (g) PPDO/0.5%GO. Scale bars: 1 mm. Abbreviations: GO, graphene oxide; PPDO, poly(p-dioxanone);
            SEM, scanning electron microscopy.


            Volume 10 Issue 6 (2024)                       327                                doi: 10.36922/ijb.4530
   330   331   332   333   334   335   336   337   338   339   340